Cobicistat is Used for treating HIV infection by enhancing the pharmacokinetics and inhibiting cytochrome P450 monooxygenase. It was first introduced by Gilead Sciences Inc in its drug Tybost on Sep 24, 2014. 2 different companies have introduced drugs containing Cobicistat.

Cobicistat Patents

Given below is the list of patents protecting Cobicistat, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Tybost	US10039718 (Pediatric)	Use of solid carrier particles to improve the processability of a pharmaceutical agent	Apr 06, 2033	Gilead Sciences Inc
Tybost	US10039718	Use of solid carrier particles to improve the processability of a pharmaceutical agent	Oct 06, 2032	Gilead Sciences Inc
Tybost	US8148374 (Pediatric)	Modulators of pharmacokinetic properties of therapeutics	Mar 03, 2030	Gilead Sciences Inc
Tybost	US8148374	Modulators of pharmacokinetic properties of therapeutics	Sep 03, 2029	Gilead Sciences Inc

Add above patents to watchlist

Cobicistat's Family Patents

Full family tree

Cobicistat Generic API Manufacturers

Only one generic application has been filed for Cobicistat.

Given below is the list of companies who have filed for Cobicistat generic, along with the locations of their manufacturing plants worldwide.